The expression of calretinin and cytokeratins in canine acanthomatous ameloblastoma and oral squamous cell carcinoma

Veterinary and Comparative Oncology

Volumn 12, Issue 4, 2014, Pages 258-265

  Fulton, A ^a   Arzi, B ^b   Murphy, B ^a   Naydan, D K ^a   Verstraete, F J M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Calretinin; Canine acanthomatous ameloblastoma; Dog; Oral squamous cell carcinoma

Indexed keywords

CANIS FAMILIARIS;

CALRETININ; KERATIN; MONOCLONAL ANTIBODY;

AMELOBLASTOMA; ANIMAL; DOG; DOG DISEASE; IMMUNOHISTOCHEMISTRY; JAW TUMOR; METABOLISM; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TOOTH; UNITED STATES; UNIVERSITY; VETERINARY;

AMELOBLASTOMA; ANIMALS; ANTIBODIES, MONOCLONAL; CALBINDIN 2; CALIFORNIA; CARCINOMA, SQUAMOUS CELL; DOG DISEASES; DOGS; IMMUNOHISTOCHEMISTRY; JAW NEOPLASMS; KERATINS; MOUTH NEOPLASMS; TOOTH; UNIVERSITIES;

EID: 84911420277     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2012.00356.x     Document Type: Article

References (41)

1. Liptak JM and Withrow SJ. Oral tumors. In: Withrow & MacEwen's Small Animal Clinical Oncology. 4th edn., SJ Withrow and DM Vail Eds., St. Louis, Saunders Elsevier, 2007: 455-475.
2. Fiani N, Verstraete FJ, Kass PH and Cox DP. Clinicopathologic characterization of odontogenic tumors and focal fibrous hyperplasia in dogs: 152 cases (1995-2005). Journal of the American Veterinary Medical Association 2011; 238: 495-500.
3. st edn., Lyons, IARC Press, 2005.
4. rd edn., St. Louis, Saunders Elsevier, 2009.
5. Gardner DG. Canine acanthomatous epulis. The only common spontaneous ameloblastoma in animals. Oral Surgery Oral Medicine Oral Pathology Oral Radiology Endodontics 1995; 79: 612-5.
6. Verstraete FJ, Ligthelm AJ and Weber A. The histological nature of epulides in dogs. Journal of Comparative Pathology 1992; 106: 169-82.
7. Gardner DG and Baker DC. The relationship of the canine acanthomatous epulis to ameloblastoma. Journal of Comparative Pathology 1993; 108: 47-55.
8. rd edn., DH Slatter Ed., Philadelphia, WB Saunders Co, 2003: 2638-51.
9. th edn., AR Mews Ed., Ames, Iowa State Press, 2002: 402-7.
10. Dubielzig RR and Thrall DE. Ameloblastoma and keratinizing ameloblastoma in dogs. Veterinary Pathology 1982; 19: 596-607.
11. th edn., WB Saunders Co, Philadelphia, 2008.
12. Nemec A, Murphy B, Kass PH and Verstraete FJ. Histological subtypes of oral non-tonsillar squamous cell carcinoma in dogs. Journal of Comparative Pathology 2012; 147: 111-120.
13. Depondt J, Shabana AH, Sawaf H, Gehanno P and Forest N. Cytokeratin alterations as diagnostic and prognostic markers of oral and pharyngeal carcinomas. A prospective study. European Journal of Oral Science 1999; 107: 442-54.
14. Fillies T, Werkmeister R, Packeisen J, Brandt B, Morin P, Weingart D, Joos U and Buerger H. Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity. BMC Cancer. 2006; 6: 10.
15. Xu XC, Lee JS, Lippman SM, Ro JY, Hong WK and Lotan R. Increased expression of cytokeratins CK8 and CK19 is associated with head and neck carcinogenesis. Cancer Epidemiologic Biomarkers & Prevention 1995; 4: 871-6.
16. Moll R, Franke WW, Schiller DL, Geiger B and Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982; 31: 11-24.
17. Fuchs E and Cleveland DW. A structural scaffolding of intermediate filaments in health and disease. Science. 1998; 279: 514-9.
18. Crivelini MM, de Araujo VC, de Sousa SO and de Araujo NS. Cytokeratins in epithelia of odontogenic neoplasms. Oral Diseases 2003; 9: 1-6.
19. Dos Santos JN, Oliveira GQ, Gurgel CA, de Souza RO, Sales CB, de Aguiar Pires Valenca Neto A and Ramos EA. Altered expression of cytokeratins in primary, recurrent and syndrome keratocystic odontogenic tumors. Journal of Molecular Histology 2009; 40: 269-75.
20. Ordonez NG. Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma. Modern Pathology 1998; 11: 929-33.
21. Arzi B, Murphy B, Nemec A, Vapniarsky N, Naydan DK and Verstraete FJ. Expression of cytokeratins in the epithelium of canine odontogenic tumours. Journal of Comparative Pathology 2011; 145: 345-51.
22. Kumamoto H, Yoshida M and Ooya K. Immunohistochemical detection of amelogenin and cytokeratin 19 in epithelial odontogenic tumors. Oral Diseases 2001; 7: 171-6.
23. Andressen C, Blumcke I and Celio MR. Calcium-binding proteins: selective markers of nerve cells. Cell and Tissue Research 1993; 271: 181-208.
24. Rogers JH. Calretinin: a gene for a novel calcium-binding protein expressed principally in neurons. Journal of Cellular Biology 1987; 105: 1343-53.
25. Schwaller B, Buchwald P, Blumcke I, Celio MR and Hunziker W. Characterization of a polyclonal antiserum against the purified human recombinant calcium binding protein calretinin. Cell Calcium. 1993; 14: 639-48.
26. Gander JC, Gotzos V, Fellay B and Schwaller B. Inhibition of the proliferative cycle and apoptotic events in WiDr cells after down-regulation of the calcium-binding protein calretinin using antisense oligodeoxynucleotides. Experimental Cellular Research 1996; 225: 399-410.
27. Heizmann CW. Calcium-binding proteins: basic concepts and clinical implications. General Physiology and Biophysics 1992; 11: 411-25.
28. Piattelli A, Fioroni M, Iezzi G and Rubini C. Calretinin expression in odontogenic cysts. Journal of Endodontics. 2003; 29: 394-6.
29. Kiraly E and Celio MR. Parvalbumin and calretinin in the avian thymus. Anatomy and Embryology (Berlin) 1993; 188: 339-44.
30. Alaeddini M, Etemad-Moghadam S and Baghaii F. Comparative expression of calretinin in selected odontogenic tumours: a possible relationship to histogenesis. Histopathology 2008; 52: 299-304.
31. Coleman H, Altini M, Ali H, Doglioni C, Favia G and Maiorano E. Use of calretinin in the differential diagnosis of unicystic ameloblastomas. Histopathology 2001; 38: 312-7.
32. Doglioni C, Dei Tos AP, Laurino L, Iuzzolino P, Chiarelli C, Celio MR and Viale G. Calretinin: a novel immunocytochemical marker for mesothelioma. American Journal of Surgical Pathology 1996; 20: 1037-46.
33. Nel S, Van Heerden MB, Steenkamp G, Van Heerden WF and Boy SC. Immunohistochemical profile of odontogenic epithelium in developing dog teeth (Canis familiaris). Veterinary Pathology 2011; 48: 276-82.
34. Gardner DG. An orderly approach to the study of odontogenic tumours in animals. Journal of Comparative Pathology 1992; 107: 427-38.
35. Norris AJ, Naydan DK and Wilson DW. Interstitial lung disease in West Highland White Terriers. Veterinary Pathology 2005; 42: 35-41.
36. Cheuk W and Chang JK. Subcellular localization of immunohistochemical signals: knowledge of the ultrastructural or biologic features of the antigens helps predict the signal localization and proper interpretation of immunostains. International Journal of Surgical Pathology 2004; 12: 185-206.
37. Kasper M, Karsten U, Stosiek P and Moll R. Distribution of intermediate-filament proteins in the human enamel organ: unusually complex pattern of coexpression of cytokeratin polypeptides and vimentin. Differentiation 1989; 40: 207-14.
38. Ravindranath RM, Basilrose RM Sr, Ravindranath NH and Vaitheesvaran B. Amelogenin interacts with cytokeratin-5 in ameloblasts during enamel growth. Journal of Biological Chemistry 2003; 278: 20293-302.
39. Domingues MG, Jaeger MM, Araujo VC and Araujo NS. Expression of cytokeratins in human enamel organ. European Journal of Oral Science 2000; 108: 43-7.
40. van der Velden LA, Schaafsma HE, Manni JJ, Ruiter DJ, Ramaekers FC and Kuijpers W. Cytokeratin and vimentin expression in normal epithelium and squamous cell carcinomas of the larynx. European Archives of Otorhinolaryngology 1997; 254: 376-83.
41. Kishino M, Murakami S, Yuki M, Iida S, Ogawa Y, Kogo M and Toyosawa S. A immunohistochemical study of the peripheral ameloblastoma. Oral Diseases. 2007; 13: 575-80.